Total Funding
63
48
Total FundingSeries A raised
Growth Score
-10 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
45532
Singletto develops novel antimicrobial solutions and singlet oxygen technology to protect against pathogens.
Thomas Lendvay: Co-Founder & Chief Medical OfficerPast Role: CSATS, Co-Founder and Chief Medical Officer- John Bjornson: CEO
About the Company
Singletto develops novel antimicrobial solutions and singlet oxygen technology to protect against pathogens. Light-activated dyes are used in the company's solutions to generate singlet oxygen, which destroys pathogens of the common cold, seasonal flu, and COVID-19.
